Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Sell
855
-75
-8% -$23.6K 0.02% 288
2026
Q1
$306K Sell
930
-3
-0.3% -$1.08K 0.02% 269
2025
Q4
$328K Buy
933
+16
+2% +$5.83K 0.03% 256
2025
Q3
$339K Sell
917
-2
-0.2% -$773 0.03% 252
2025
Q2
$364K Sell
919
-20
-2% -$7.48K 0.03% 245
2025
Q1
$350K Buy
939
+109
+13% +$41.5K 0.03% 245
2024
Q4
$299K Sell
830
-2
-0.2% -$741 0.03% 256
2024
Q3
$301K Buy
832
+5
+0.6% +$1.73K 0.03% 242
2024
Q2
$281K Hold
827
0.03% 232
2024
Q1
$296K Hold
827
0.04% 220
2023
Q4
$248K Sell
827
-150
-15% -$42.1K 0.03% 229
2023
Q3
$267K Buy
+977
New +$280K 0.04% 228

Other funds holding SYK

CGN Advisors's SYK Position: Q2 2026 in Review

CGN Advisors reduced its Stryker (SYK) stake by 8.1% in Q2 2026, selling an estimated $23.6K and leaving 855 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #288.

CGN Advisors first reported a position in SYK in Q3 2023 and has held it in 12 quarters since. The position peaked at $364K in Q2 2025. 390 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • CGN Advisors held 855 shares of Stryker worth $269K as of Q2 2026.
  • CGN Advisors sold 75 Stryker shares in Q2 2026, an estimated $23.6K.
  • Stryker made up 0.02% of CGN Advisors's portfolio in Q2 2026, its #288 holding.
  • CGN Advisors first reported a position in Stryker in Q3 2023 and has held it in 12 quarters since.
  • CGN Advisors's Stryker position peaked at $364K in Q2 2025.
  • 390 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.